Released Aug 13, 2019, after the close
10-Q filed Aug 13, 2019, 44 days after period end · 0001213900-19-015578
Q2 2019 · 10-Q
Revenue—
Net Income-$8.81M-$8.81M no prior Q2 2018 on fileN/M vs Q1 2019
EPS Diluted-$1.33-$1.33 no prior Q2 2018 on fileno prior Q1 2019 on file
Operating Income-$8,673,000—
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
no prior Q2 2018 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Compass Therapeutics, Inc. · CIK 1738021 · Engraved from SEC EDGAR